SEC Form 4 · accession 0001644250-15-000006
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd E Simpson
Officer — Chief Financial Officer
Period of report
Sep 29, 2015
Accepted (ET)
Oct 1, 2015 · 3:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 29, 2015 | M | 6,468 | $15.46 | A | 186,342 | D | |
| Common Stock | Sep 29, 2015 | M | 8,333 | $12.00 | A | 194,675 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $12.00 | Sep 29, 2015 | M | 8,333 | D | — | Aug 27, 2020 | Common Stock | 8,333 | 0 | D |
| Incentive Stock Option (right to buy)F2 | $15.46 | Sep 29, 2015 | M | 6,468 | D | — | Aug 24, 2021 | Common Stock | 6,468 | 0 | D |
Explanation of responses
- F1Shares vested at a rate of 25% on 8/27/11 and monthly thereafter until all the shares were fully vested on 8/27/14.
- F2Shares vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15.